Harmony Biosciences Holdings, Inc. (HRMY)
41.52
+0.42
(+1.02%)
USD |
NASDAQ |
Sep 11, 16:00
41.52
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Price : 41.52 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 41.30 | 41.72 | 40.92 | 41.52 | 1.123M |
| Sep 10, 2026 | 41.26 | 41.72 | 40.93 | 41.10 | 736834.0 |
| Sep 09, 2026 | 42.01 | 42.40 | 41.23 | 41.62 | 1.133M |
| Sep 08, 2026 | 42.20 | 43.25 | 41.56 | 42.07 | 1.778M |
| Sep 04, 2026 | 41.50 | 42.34 | 41.36 | 42.25 | 662547.0 |
| Sep 03, 2026 | 42.93 | 43.49 | 41.40 | 41.86 | 1.101M |
| Sep 02, 2026 | 41.31 | 43.02 | 41.25 | 42.86 | 1.167M |
| Sep 01, 2026 | 39.38 | 41.49 | 39.38 | 41.25 | 894900.0 |
| Aug 31, 2026 | 38.97 | 39.74 | 38.97 | 39.38 | 560160.0 |
| Aug 28, 2026 | 39.69 | 39.69 | 39.13 | 39.21 | 590218.0 |
| Aug 27, 2026 | 39.90 | 40.00 | 39.16 | 39.87 | 499043.0 |
| Aug 26, 2026 | 39.74 | 40.50 | 38.86 | 39.66 | 745198.0 |
| Aug 25, 2026 | 38.56 | 39.22 | 38.34 | 38.95 | 375522.0 |
| Aug 24, 2026 | 38.13 | 38.93 | 37.48 | 38.50 | 486067.0 |
| Aug 21, 2026 | 38.12 | 38.84 | 38.02 | 38.15 | 380083.0 |
| Aug 20, 2026 | 39.61 | 40.02 | 37.93 | 38.07 | 696099.0 |
| Aug 19, 2026 | 39.05 | 39.99 | 38.51 | 39.93 | 765793.0 |
| Aug 18, 2026 | 38.19 | 39.11 | 38.15 | 38.83 | 463479.0 |
| Aug 17, 2026 | 38.12 | 38.53 | 37.75 | 38.14 | 734284.0 |
| Aug 14, 2026 | 38.22 | 38.46 | 37.87 | 38.12 | 388569.0 |
| Aug 13, 2026 | 39.89 | 40.15 | 38.43 | 38.50 | 582635.0 |
| Aug 12, 2026 | 39.16 | 39.83 | 39.03 | 39.77 | 693497.0 |
| Aug 11, 2026 | 38.90 | 39.56 | 38.62 | 39.52 | 557488.0 |
| Aug 10, 2026 | 38.41 | 39.34 | 38.26 | 39.00 | 564502.0 |
| Aug 07, 2026 | 39.20 | 39.43 | 38.20 | 38.41 | 994523.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Liquidia Corp. | 66.74 |
| Repligen Corp. | 165.18 |
| Johnson & Johnson | 265.58 |
| Pfizer Inc. | 27.72 |
| Bristol Myers Squibb Co. | 63.64 |
Price Related Metrics
| PE Ratio | 13.45 |
| PS Ratio | 2.541 |
| Price to Book Value | 2.415 |
| Price to Free Cash Flow | 7.266 |
| Earnings Yield | 7.43% |
| Market Cap | 2.413B |
| Operating PE Ratio | 10.57 |
| Normalized PE Ratio | 13.45 |